Pharmacokinetics and safety of cefamandole in newborn infants

M. M. Agbayani, A. J. Khan, P. Kemawikasit, W. Rosenfeld, D. Salazar, K. Kumar, L. Glass, H. E. Evans

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Cefamandole, a new parenteral cephalosporin antibiotic, was administered to 23 newborn infants with pustular skin infection due to Staphylococcus aureus for an average duration of 7.5 days. All the patients improved clinically. Elevation of serum glutamic oxaloacetic transaminase nad eosinophilia were observed in nine infants each transiently during treatment. There were no abnormalities of renal functions and Coombs' test results remained negative. The levels of cefamandole in serum after either intravenous or intramuscular administration were higher and the mean life was longer than those previously reported in older infants, children, and adults.

Original languageEnglish (US)
Pages (from-to)674-676
Number of pages3
JournalUnknown Journal
Volume15
Issue number5
DOIs
StatePublished - Jan 1 1979

Fingerprint

Cefamandole
Pharmacokinetics
Newborn Infant
Safety
Coombs Test
Eosinophilia
Cephalosporins
Aspartate Aminotransferases
Staphylococcus aureus
Kidney
Skin
Infection
Serum
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Agbayani, M. M., Khan, A. J., Kemawikasit, P., Rosenfeld, W., Salazar, D., Kumar, K., ... Evans, H. E. (1979). Pharmacokinetics and safety of cefamandole in newborn infants. Unknown Journal, 15(5), 674-676. https://doi.org/10.1128/AAC.15.5.674
Agbayani, M. M. ; Khan, A. J. ; Kemawikasit, P. ; Rosenfeld, W. ; Salazar, D. ; Kumar, K. ; Glass, L. ; Evans, H. E. / Pharmacokinetics and safety of cefamandole in newborn infants. In: Unknown Journal. 1979 ; Vol. 15, No. 5. pp. 674-676.
@article{a9ba098534264d6b80425df5e7542c67,
title = "Pharmacokinetics and safety of cefamandole in newborn infants",
abstract = "Cefamandole, a new parenteral cephalosporin antibiotic, was administered to 23 newborn infants with pustular skin infection due to Staphylococcus aureus for an average duration of 7.5 days. All the patients improved clinically. Elevation of serum glutamic oxaloacetic transaminase nad eosinophilia were observed in nine infants each transiently during treatment. There were no abnormalities of renal functions and Coombs' test results remained negative. The levels of cefamandole in serum after either intravenous or intramuscular administration were higher and the mean life was longer than those previously reported in older infants, children, and adults.",
author = "Agbayani, {M. M.} and Khan, {A. J.} and P. Kemawikasit and W. Rosenfeld and D. Salazar and K. Kumar and L. Glass and Evans, {H. E.}",
year = "1979",
month = "1",
day = "1",
doi = "10.1128/AAC.15.5.674",
language = "English (US)",
volume = "15",
pages = "674--676",
journal = "Unknown Journal",
number = "5",

}

Agbayani, MM, Khan, AJ, Kemawikasit, P, Rosenfeld, W, Salazar, D, Kumar, K, Glass, L & Evans, HE 1979, 'Pharmacokinetics and safety of cefamandole in newborn infants', Unknown Journal, vol. 15, no. 5, pp. 674-676. https://doi.org/10.1128/AAC.15.5.674

Pharmacokinetics and safety of cefamandole in newborn infants. / Agbayani, M. M.; Khan, A. J.; Kemawikasit, P.; Rosenfeld, W.; Salazar, D.; Kumar, K.; Glass, L.; Evans, H. E.

In: Unknown Journal, Vol. 15, No. 5, 01.01.1979, p. 674-676.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pharmacokinetics and safety of cefamandole in newborn infants

AU - Agbayani, M. M.

AU - Khan, A. J.

AU - Kemawikasit, P.

AU - Rosenfeld, W.

AU - Salazar, D.

AU - Kumar, K.

AU - Glass, L.

AU - Evans, H. E.

PY - 1979/1/1

Y1 - 1979/1/1

N2 - Cefamandole, a new parenteral cephalosporin antibiotic, was administered to 23 newborn infants with pustular skin infection due to Staphylococcus aureus for an average duration of 7.5 days. All the patients improved clinically. Elevation of serum glutamic oxaloacetic transaminase nad eosinophilia were observed in nine infants each transiently during treatment. There were no abnormalities of renal functions and Coombs' test results remained negative. The levels of cefamandole in serum after either intravenous or intramuscular administration were higher and the mean life was longer than those previously reported in older infants, children, and adults.

AB - Cefamandole, a new parenteral cephalosporin antibiotic, was administered to 23 newborn infants with pustular skin infection due to Staphylococcus aureus for an average duration of 7.5 days. All the patients improved clinically. Elevation of serum glutamic oxaloacetic transaminase nad eosinophilia were observed in nine infants each transiently during treatment. There were no abnormalities of renal functions and Coombs' test results remained negative. The levels of cefamandole in serum after either intravenous or intramuscular administration were higher and the mean life was longer than those previously reported in older infants, children, and adults.

UR - http://www.scopus.com/inward/record.url?scp=0018763966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018763966&partnerID=8YFLogxK

U2 - 10.1128/AAC.15.5.674

DO - 10.1128/AAC.15.5.674

M3 - Article

C2 - 525985

AN - SCOPUS:0018763966

VL - 15

SP - 674

EP - 676

JO - Unknown Journal

JF - Unknown Journal

IS - 5

ER -

Agbayani MM, Khan AJ, Kemawikasit P, Rosenfeld W, Salazar D, Kumar K et al. Pharmacokinetics and safety of cefamandole in newborn infants. Unknown Journal. 1979 Jan 1;15(5):674-676. https://doi.org/10.1128/AAC.15.5.674